Patrick Reeves

Person

Boston, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Modified natural killer cells for the treatment of cancer
- Patent number 11,419,894
- Issue date Aug 23, 2022
- The General Hospital Corporation
- Mark C. Poznansky
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-fugetactic agent and anti-cancer agent combination therapy and...
- Patent number 11,305,017
- Issue date Apr 19, 2022
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHODS FOR IDENTIFYING CROSS-MODAL FEATURES FROM SPATIALLY RESOLVE...
- Publication number 20230306761
- Publication date Sep 28, 2023
- The General Hospital Corporation
- Ruxandra F. SIRBULESCU
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
ANTI-FUGETACTIC AGENT AND ANTI-CANCER AGENT COMBINATION THERAPY AND...
- Publication number 20220226474
- Publication date Jul 21, 2022
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-FUGETACTIC AGENT AND ANTI-CANCER AGENT COMBINATION THERAPY AND...
- Publication number 20200093928
- Publication date Mar 26, 2020
- The General Hospital Corporation
- Mark C. Poznansky
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cancer Treatment with a CXCL12 Signaling Inhibitor and an Immune Ch...
- Publication number 20200093789
- Publication date Mar 26, 2020
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED NATURAL KILLER CELLS FOR THE TREATMENT OF CANCER
- Publication number 20190269729
- Publication date Sep 5, 2019
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF TUMORS WITH INHIBITORS OF CXCL12 SIGNALING AND SUBTHER...
- Publication number 20190133998
- Publication date May 9, 2019
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
UNIT DOSE FORMULATIONS FOR USE AS AN ANTI-FUGETACTIC AGENT
- Publication number 20180353472
- Publication date Dec 13, 2018
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED IMMUNE CELLS AND USES THEREOF
- Publication number 20180325953
- Publication date Nov 15, 2018
- APERISYS, INC.
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-FUGETACTIC AGENT AND IMMUNOTHERAPY AGENT COMBINATION THERAPY A...
- Publication number 20180117006
- Publication date May 3, 2018
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-FUGETACTIC AGENT AND ANTI-CANCER AGENT COMBINATION THERAPY AND...
- Publication number 20180117155
- Publication date May 3, 2018
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS FOR THE TREATMENT OF CANCER
- Publication number 20180117005
- Publication date May 3, 2018
- Patrick Reeves
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patrick Reeves

Person

Patents Grantslast 30 patents

Modified natural killer cells for the treatment of cancer

Anti-fugetactic agent and anti-cancer agent combination therapy and...

Patents Applicationslast 30 patents

METHODS FOR IDENTIFYING CROSS-MODAL FEATURES FROM SPATIALLY RESOLVE...

ANTI-FUGETACTIC AGENT AND ANTI-CANCER AGENT COMBINATION THERAPY AND...

ANTI-FUGETACTIC AGENT AND ANTI-CANCER AGENT COMBINATION THERAPY AND...

Cancer Treatment with a CXCL12 Signaling Inhibitor and an Immune Ch...

MODIFIED NATURAL KILLER CELLS FOR THE TREATMENT OF CANCER

TREATMENT OF TUMORS WITH INHIBITORS OF CXCL12 SIGNALING AND SUBTHER...

UNIT DOSE FORMULATIONS FOR USE AS AN ANTI-FUGETACTIC AGENT

MODIFIED IMMUNE CELLS AND USES THEREOF

ANTI-FUGETACTIC AGENT AND IMMUNOTHERAPY AGENT COMBINATION THERAPY A...

ANTI-FUGETACTIC AGENT AND ANTI-CANCER AGENT COMBINATION THERAPY AND...

COMPOSITIONS FOR THE TREATMENT OF CANCER